Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
9798
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
IST1 factor associated with ESCRT-III |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
IST1 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
CHMP8, OLC1 |
Chromosome
Chromosome number
|
16 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
16q22.2 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
This gene encodes a protein with MIT-interacting motifs that interacts with components of endosomal sorting complexes required for transport (ESCRT). ESCRT functions in vesicle budding, such as that which occurs during membrane abscission in cytokinesis. |
UniProt ID |
P53990
|
Protein name |
IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28) |
Protein function |
ESCRT-III-like protein involved in cytokinesis, nuclear envelope reassembly and endosomal tubulation (PubMed:19129479, PubMed:26040712, PubMed:28242692). Is required for efficient abscission during cytokinesis (PubMed:19129479). Involved in recr |
PDB |
3FRR
,
3FRS
,
3JC1
,
4U7E
,
4U7I
,
4U7Y
,
4WZX
,
6E8G
,
6TZ4
,
6TZ5
,
6TZA
,
7S7J
,
8UC6
,
8V2Q
,
8V2R
,
8V2S
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF03398
|
Ist1 |
12 → 176 |
Regulator of Vps4 activity in the MVB pathway |
Family |
|
Sequence |
|
Sequence length |
364 |
Interactions |
View interactions
|
Causal |
Disease term |
Disease name |
dbSNP ID |
References |
Breast carcinoma |
Breast Carcinoma |
rs80359671, rs11540652, rs28934575, rs28897672, rs137886232, rs193922376, rs80357783, rs80359306, rs80359405, rs80359507, rs80359598, rs80358429, rs397507683, rs397515636, rs80359451, rs397507859, rs80359709, rs80359742, rs80359205, rs80357627, rs80357004, rs80357571, rs80357767, rs80357653, rs80358086, rs80357608, rs28897696, rs41293465, rs146650273, rs63751017, rs63750617, rs63750726, rs63750199, rs63749848, rs398122618, rs398122653, rs397509211, rs80357791, rs121912666, rs587778541, rs121908698, rs536907995, rs587781302, rs140342925, rs587781506, rs587782652, rs587782849, rs587783057, rs139770721, rs374950566, rs786202800, rs863224451, rs377153250, rs747727055, rs876658804, rs780001540, rs760815829, rs878854926, rs775248597, rs886040658, rs886040192, rs786203523, rs886040319, rs397508006, rs587782011, rs1060502772, rs1555461727, rs1553333072, rs1114167702, rs1257401983, rs886040950, rs1060502759, rs774684620, rs142947311, rs1555580883, rs748513310, rs376170600, rs863224499, rs1593909229, rs748453607, rs1294578913, rs1574737047, rs1593909960, rs2081922847, rs2082559544, rs2053694038 View all (71 more) |
29059683 |
|
Unknown |
Disease term |
Disease name |
Evidence |
References |
Source |
Breast Cancer |
Breast Cancer |
Importantly, breast cancer patients bearing PRC2 LOF mutations displayed significantly worse prognosis compared with PRC2 wild-type patients |
|
GWAS, CBGDA |
|
Associations from Text Mining |
Disease Name |
Relationship Type |
References |
Breast Neoplasms |
Stimulate
|
24880589 |
Carcinogenesis |
Associate
|
28038462 |
Carcinoma in Situ |
Stimulate
|
24608342 |
Drug Related Side Effects and Adverse Reactions |
Associate
|
24608342 |
Esophageal Neoplasms |
Associate
|
24608342 |
Esophageal Squamous Cell Carcinoma |
Stimulate
|
24608342 |
Hearing Loss |
Associate
|
33924653 |
Lymphatic Metastasis |
Associate
|
24880589 |
Neoplasm Invasiveness |
Associate
|
24608342 |
Retinal Dysplasia |
Associate
|
24608342 |
Stomach Neoplasms |
Associate
|
28038462 |
|